Biobank for Inflammatory Chronic Diseases and Osteoporosis

  • End date
    Sep 1, 2031
  • participants needed
  • sponsor
    University Hospital, Toulouse
Updated on 26 September 2021
rheumatoid arthritis
psoriatic arthritis
secondary osteoporosis


The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.


Biologic ant targeted synthetic disease modifying anti-rheumatic drugs (bDMARDs and tsDMARDs) have greatly improved the prognosis of chronic inflammatory diseases. To date, many bDMARDs and tsDMARDs targeting different immunologic mechanisms are available to treat RA, SpA or PsA. However, the choice of the treatment and its mechanism of action is based on physician decision and experience. Indeed, predictive clinical and biological factors associated with therapeutic response that could help the physician to make his/her choice are lacking. The aim of BIO-TOUL is to collect and store biologic samples in patients with RA, SpA or PsA who begin a new bDMARD or tsDMARD. This biobank will permit to study several biomarkers and assess the association between such markers and response to therapy.

Furthermore, osteoporosis is a chronic disease leading to fractures and disability. Several ant-osteoporotic drugs are now available and biomarker(s) that would help the physician to choose the best therapeutic sequence are lacking. BIO-TOUL will also include patients with osteoporosis to identify biomarkers associated with severity and response to anti-osteoporotic treatments.

Condition Spondylarthritis, spondyloarthritis, Psoriasis, Arthritis, Rheumatoid Arthritis (Pediatric), PSORIATIC ARTHRITIS, Arthritis and Arthritic Pain, Rheumatoid Arthritis, Osteoporosis, Arthritis and Arthritic Pain (Pediatric), Spondyloarthropathy, Psoriasis and Psoriatic Disorders, Osteopenia, Psoriatic Arthritis
Treatment blood sampling
Clinical Study IdentifierNCT05039216
SponsorUniversity Hospital, Toulouse
Last Modified on26 September 2021


Yes No Not Sure

Inclusion Criteria

Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
Aged > 18 ans
With National Health Assurance
Able to consent to the study

Exclusion Criteria

Pregnancy or breastfeeding
Not able to give a consent
Severe anemia (Hb<10g/L)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note